Southern California

Welcome to the AAPS Southern California Pharmaceutical Discussion Group Page

The Southern California Pharmaceutical discussion group (SCPDG) is a local discussion group affiliated with AAPS. SCPDG is an organization focused on fostering education in and knowledge of the pharmaceutical sciences, its industry, and regulations. The meetings provide a local forum for scientific exchange for members within Orange, Los Angeles and San Diego, Calif., counties.

By joining the SCPDG, you will be included in a dynamic and active group of dedicated professionals. Meetings are typically held on the second Thursday of the month in Orange County. Hors d’oeuvres, dinner, and networking will be from 6 pm–7 pm. Speaker presentations begin at 7 pm, followed by a question-and-answer session. Topics and speakers are chosen from suggestions made by members (i.e., pharmaceutical technology, drug and chemical delivery, analysis, toxicology, biotechnology, pharmacokinetics, drug metabolism, etc.).

SCPDG PhotoFrom left to right, front: Xiaoda Yuan, Martha Pastuszka, Adam Grobin; back: Ke Wu, Emily Bibak, Linda Soo Hoo, and Bobette Frye.

Join

Upcoming Events

Analytical Method Life Cycle/QbD in the Analytical Laboratory

January 14, 2021 at 5:30 – 6:30 PM
Read More!


Past Presentations

Take a look at our past presentations below.

Social Media

Check out our LinkedIn group! 

Presentation 14

Quality Paradigm Shifts in the Pharmaceutical Landscape and Proposed Solutions

2022
Jane Weitzel

View full presentation (PDF)

Presentation 13

GMP Laboratory Compliance and Case Studies of Observations at Contract Laboratories

2021
Sunil DeSouza
View full presentation (PDF)

Presentation 12

Glycosylation in Biotherapeutics:
Why it Matters and Recent Advances in Analysis

2021
Arnie Aistars

View full presentation (PDF)

Presentation 11

CCI Overview and USP 1207 Guidance

2021
Zecchin

View full presentation (PDF)

Presentation 10

CMC Challenges of expedited programs

2020
James Bernstein
View full presentation (PDF)

Presentation 9

API Development: Strategy and Best Practices in the Pharmaceutical Industry

2020
Ashok V. Bhatia

View full presentation (PDF)

Presentation 8

NBCD Products (nonbiological complex drug) & OCAT™ Ocular Compartmental Absorption & Transit Model : Bioequivalence Reviews

2020
Hovik Gukasyan

View full presentation (PDF)

Presentation 7

Phase-Appropriate GMP for Gene and Cell Therapy

2020
Trevor Deeks
View full presentation (PDF)

Presentation 6

Novel Cell Culture Models for
Mimicking the Human Blood-Brain
Barrier

2019
Aimable Ngendahimana

View full presentation (PDF)

Presentation 5

Downstream Development and Market Considerations that Impact Drug Discovery

2019
Vince Wacher

View full presentation (PDF)

Presentation 4

Best Practices for Effective Tablet Lubrication

2019
Tony Carpanzano 
View full presentation (PDF)

Presentation 3

Data Integrity Shortfalls in the Laboratory: Lessons from Warning Letters

2017
Toa Wang

View full presentation (PDF)

Presentation 2

Assessment and Control of Mutagenic Impurities per ICH Guidelines (M7) with Case Studies

2017
Steven Kuwahara

View full presentation (PDF)

Presentation 1

Phase Appropriate Method Validation

2017
Aryo Nikopour
View full presentation (PDF)